Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma

被引：0
|
作者：
Fei Teng
Ju-Xiang Zhang
Qi-Meng Chang
Xu-Bo Wu
Wei-Guo Tang
Jian-Fa Wang
Jin-Feng Feng
Zi-Ping Zhang
Zhi-Qiu Hu
机构：
[1] Fudan University,Department of Hepatobiliary and Pancreatic Surgery, Minhang Hospital
[2] Fudan University,Institute of Fudan
[3] Shanghai Jiao Tong University,Minhang Academic Health System, Minhang Hospital
来源：
Journal of Experimental & Clinical Cancer Research | / 39卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
An amendment to this paper has been published and can be accessed via the original article.
引用
收藏
相关论文
共 50 条
  • [1] LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma (vol 39, 235, 2020)
    Teng, Fei
    Zhang, Ju-Xiang
    Chang, Qi-Meng
    Wu, Xu-Bo
    Tang, Wei-Guo
    Wang, Jian-Fa
    Feng, Jin-Feng
    Zhang, Zi-Ping
    Hu, Zhi-Qiu
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 39 (01)
  • [2] Correction: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGF R-2 signaling pathway in hepatocellular carcinoma
    Fei Teng
    Ju-Xiang Zhang
    Qi-Meng Chang
    Xu-Bo Wu
    Wei-Guo Tang
    Jian-Fa Wang
    Jin-Feng Feng
    Zi-Ping Zhang
    Zhi-Qiu Hu
    Journal of Experimental & Clinical Cancer Research, 42
  • [3] LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGF R-2 signaling pathway in hepatocellular carcinoma (vol 39, 235, 2020)
    Teng, Fei
    Zhang, Ju-Xiang
    Chang, Qi-Meng
    Wu, Xu-Bo
    Tang, Wei-Guo
    Wang, Jian-Fa
    Feng, Jin-Feng
    Zhang, Zi-Ping
    Hu, Zhi-Qiu
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42 (01)
  • [4] MiR-424-5p regulates cell cycle and inhibits proliferation of hepatocellular carcinoma cells by targeting E2F7
    Zhao, Yichao
    Zhu, Chaoqian
    Chang, Qing
    Peng, Peng
    Yang, Jie
    Liu, Chunmei
    Liu, Yang
    Chen, Xiaonan
    Liu, Yuanguang
    Cheng, Ran
    Wu, Yijie
    Wu, Xiaotang
    Hu, Liang
    Yin, Jun
    PLOS ONE, 2020, 15 (11):
  • [5] CircLATS2 Regulates miR-520a-3p/E2F7/p-VEGFR2 Signaling Pathway to Promote Hepatocellular Carcinoma Progression and Angiogenesis
    Wu, Yefeng
    Yuan, Jianmao
    Tu, Zhengbin
    Chen, Huahua
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [6] MiR-424-5p suppresses tumor growth and progression by directly targeting CHEK1 and activating cell cycle pathway in Hepatocellular Carcinoma
    Yin, Chunlin
    Sun, Yuansong
    Li, He
    Zheng, Xianxian
    HELIYON, 2024, 10 (18)
  • [7] lncRNA ENST00000585827 Contributes to the Progression of Endometrial Carcinoma via Regulating miR-424/E2F6/E2F7 Axis
    Fang, Derong
    Zhang, Qiang
    Mu, Maoling
    Deng, Qingfang
    Wang, Yun
    Li, Quan
    APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2023, 195 (05) : 3096 - 3108
  • [8] lncRNA ENST00000585827 Contributes to the Progression of Endometrial Carcinoma via Regulating miR-424/E2F6/E2F7 Axis
    Derong Fang
    Qiang Zhang
    Maoling Mu
    Qingfang Deng
    Yun Wang
    Quan Li
    Applied Biochemistry and Biotechnology, 2023, 195 : 3096 - 3108
  • [9] Circular RNA hsa_circ_0000519 contributes to angiogenesis and tumor progression in hepatocellular carcinoma through the miR-1296/E2F7 axis
    Yi Liu
    Hui Tang
    Yaling Zhang
    Qian Wang
    Shiying Li
    Zhiyi Wang
    Xiaofeng Shi
    Human Cell, 2023, 36 : 738 - 751
  • [10] Circular RNA hsa_circ_0000519 contributes to angiogenesis and tumor progression in hepatocellular carcinoma through the miR-1296/E2F7 axis
    Liu, Yi
    Tang, Hui
    Zhang, Yaling
    Wang, Qian
    Li, Shiying
    Wang, Zhiyi
    Shi, Xiaofeng
    HUMAN CELL, 2023, 36 (02) : 738 - 751
12345